US Stock MarketDetailed Quotes

Gyre Therapeutics (GYRE)

Watchlist
  • 7.700
  • +0.010+0.13%
Close Jan 15 16:00 ET
  • 7.700
  • 0.0000.00%
Post 16:10 ET
699.86MMarket Cap192.50P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gyre Therapeutics (GYRE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
19.92%30.56M
6.13%26.77M
-18.82%22.06M
-6.78%105.76M
2.67%27.87M
-20.45%25.49M
-13.99%25.23M
8.99%27.17M
10.91%113.45M
27.15M
Operating revenue
19.92%30.56M
6.13%26.77M
-18.82%22.06M
-6.78%105.76M
2.67%27.87M
-20.45%25.49M
-13.99%25.23M
8.99%27.17M
10.91%113.45M
--27.15M
Cost of revenue
69.94%1.63M
49.48%1.15M
-8.68%894K
-16.22%3.88M
-5.84%1.18M
-19.09%958K
-28.51%770K
-12.98%979K
-3.28%4.64M
1.25M
Gross profit
17.96%28.94M
4.76%25.62M
-19.20%21.16M
-6.38%101.87M
3.08%26.7M
-20.51%24.53M
-13.44%24.46M
10.03%26.19M
11.61%108.81M
25.9M
Operating expense
8.44%22.01M
10.64%23.45M
4.24%18.89M
-4.42%85.64M
-16.26%26.03M
12.18%20.3M
-8.96%21.19M
5.72%18.12M
1.48%89.6M
31.09M
Selling and administrative expenses
12.13%19.65M
12.25%20.02M
-0.90%15.8M
-2.90%73.62M
-15.83%22.32M
16.16%17.52M
-9.50%17.84M
9.88%15.94M
5.88%75.82M
--26.52M
-Selling and marketing expense
11.89%15.33M
5.41%15.19M
-13.56%10.84M
-5.96%57.51M
2.38%16.86M
-1.64%13.7M
-19.92%14.41M
-1.77%12.54M
12.76%61.16M
--16.46M
-General and administrative expense
12.97%4.32M
41.03%4.83M
45.82%4.96M
9.87%16.11M
-45.66%5.46M
230.42%3.82M
100.12%3.42M
95.40%3.4M
-15.59%14.66M
--10.06M
Research and development costs
-14.85%2.36M
2.09%3.43M
41.84%3.1M
-12.74%12.02M
-18.74%3.71M
-7.78%2.78M
-5.97%3.36M
-17.19%2.18M
-17.42%13.78M
--4.57M
Operating profit
63.62%6.93M
-33.42%2.17M
-71.84%2.27M
-15.53%16.23M
112.78%663K
-66.84%4.23M
-34.42%3.26M
21.11%8.07M
108.77%19.21M
-5.19M
Net non-operating interest income expense
48.18%1.55M
6.13%346K
84.81%523K
39.44%350K
78.26%328K
43.80%1.04M
326K
Non-operating interest income
----
----
----
48.18%1.55M
6.13%346K
84.81%523K
----
78.26%328K
--1.04M
--326K
Total other finance cost
----
----
----
----
----
----
-39.44%-350K
----
----
----
Other net income (expense)
332.01%703K
-97.62%66K
-46.44%2.36M
105.60%5.44M
98.49%-1.44M
83.70%-303K
340.86%2.77M
864.30%4.41M
-18,705.03%-97.22M
-95.42M
Gain on sale of security
89.91%-23K
-92.72%212K
-47.41%2.26M
177.39%7.17M
--194K
---228K
--2.91M
--4.29M
---9.26M
----
Special income (charges)
---1K
98.53%-1K
----
99.92%-66K
100.00%2K
--0
---68K
----
---86.44M
---85.92M
-Less:Other special charges
----
----
----
----
----
----
----
----
--83.1M
----
-Gain on sale of business
----
----
----
--0
----
----
----
----
---2.71M
----
-Gain on sale of property,plant,equipment
---1K
98.53%-1K
----
89.49%-66K
101.96%2K
--0
---68K
----
---628K
---102K
Other non- operating income (expenses)
1,069.33%727K
-101.39%-145K
-12.30%107K
-9.29%-1.66M
-589.45%-1.63M
94.37%-75K
-111.45%-72K
121.14%122K
-193.62%-1.52M
---237K
Income before tax
94.12%7.63M
-62.92%2.24M
-62.86%4.64M
130.17%23.22M
100.77%772K
-64.87%3.93M
3.09%6.04M
99.03%12.48M
-917.73%-76.97M
-100.28M
Income tax
57.64%1.69M
-55.78%662K
-64.61%901K
-37.52%5.32M
-70.96%203K
-70.80%1.07M
-28.17%1.5M
23.95%2.55M
67.03%8.52M
699K
Net income
107.84%5.94M
-65.27%1.58M
-62.42%3.73M
120.94%17.9M
100.56%569K
-61.97%2.86M
20.37%4.54M
135.59%9.94M
-2,081.46%-85.48M
-100.98M
Net income continuous Operations
107.84%5.94M
-65.27%1.58M
-62.42%3.73M
120.94%17.9M
100.56%569K
-61.97%2.86M
20.37%4.54M
135.59%9.94M
-2,081.46%-85.48M
---100.98M
Minority interest income
34.30%2.33M
12.28%1.13M
-56.89%1.04M
-22.00%5.81M
2,203.45%668K
-50.99%1.73M
-47.31%1.01M
21.79%2.4M
270.43%7.45M
29K
Net income attributable to the parent company
221.17%3.61M
-87.47%442K
-64.18%2.7M
113.00%12.09M
99.90%-99K
-71.73%1.12M
90.39%3.53M
235.65%7.53M
-4,137.05%-92.93M
-101.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
221.17%3.61M
-87.47%442K
-64.18%2.7M
113.00%12.09M
99.90%-99K
-71.73%1.12M
90.39%3.53M
235.65%7.53M
-4,137.05%-92.93M
-101.01M
Basic earnings per share
300.00%0.04
0
-66.67%0.03
109.93%0.14
0
-80.74%0.01
65.32%0.04
207.16%0.09
-4,790.77%-1.41
-1.3187
Diluted earnings per share
200.00%0.03
0
0
103.55%0.05
0
-80.74%0.01
-58.67%0.01
2.39%0.03
-4,790.77%-1.41
-1.3187
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 19.92%30.56M6.13%26.77M-18.82%22.06M-6.78%105.76M2.67%27.87M-20.45%25.49M-13.99%25.23M8.99%27.17M10.91%113.45M27.15M
Operating revenue 19.92%30.56M6.13%26.77M-18.82%22.06M-6.78%105.76M2.67%27.87M-20.45%25.49M-13.99%25.23M8.99%27.17M10.91%113.45M--27.15M
Cost of revenue 69.94%1.63M49.48%1.15M-8.68%894K-16.22%3.88M-5.84%1.18M-19.09%958K-28.51%770K-12.98%979K-3.28%4.64M1.25M
Gross profit 17.96%28.94M4.76%25.62M-19.20%21.16M-6.38%101.87M3.08%26.7M-20.51%24.53M-13.44%24.46M10.03%26.19M11.61%108.81M25.9M
Operating expense 8.44%22.01M10.64%23.45M4.24%18.89M-4.42%85.64M-16.26%26.03M12.18%20.3M-8.96%21.19M5.72%18.12M1.48%89.6M31.09M
Selling and administrative expenses 12.13%19.65M12.25%20.02M-0.90%15.8M-2.90%73.62M-15.83%22.32M16.16%17.52M-9.50%17.84M9.88%15.94M5.88%75.82M--26.52M
-Selling and marketing expense 11.89%15.33M5.41%15.19M-13.56%10.84M-5.96%57.51M2.38%16.86M-1.64%13.7M-19.92%14.41M-1.77%12.54M12.76%61.16M--16.46M
-General and administrative expense 12.97%4.32M41.03%4.83M45.82%4.96M9.87%16.11M-45.66%5.46M230.42%3.82M100.12%3.42M95.40%3.4M-15.59%14.66M--10.06M
Research and development costs -14.85%2.36M2.09%3.43M41.84%3.1M-12.74%12.02M-18.74%3.71M-7.78%2.78M-5.97%3.36M-17.19%2.18M-17.42%13.78M--4.57M
Operating profit 63.62%6.93M-33.42%2.17M-71.84%2.27M-15.53%16.23M112.78%663K-66.84%4.23M-34.42%3.26M21.11%8.07M108.77%19.21M-5.19M
Net non-operating interest income expense 48.18%1.55M6.13%346K84.81%523K39.44%350K78.26%328K43.80%1.04M326K
Non-operating interest income ------------48.18%1.55M6.13%346K84.81%523K----78.26%328K--1.04M--326K
Total other finance cost -------------------------39.44%-350K------------
Other net income (expense) 332.01%703K-97.62%66K-46.44%2.36M105.60%5.44M98.49%-1.44M83.70%-303K340.86%2.77M864.30%4.41M-18,705.03%-97.22M-95.42M
Gain on sale of security 89.91%-23K-92.72%212K-47.41%2.26M177.39%7.17M--194K---228K--2.91M--4.29M---9.26M----
Special income (charges) ---1K98.53%-1K----99.92%-66K100.00%2K--0---68K-------86.44M---85.92M
-Less:Other special charges ----------------------------------83.1M----
-Gain on sale of business --------------0-------------------2.71M----
-Gain on sale of property,plant,equipment ---1K98.53%-1K----89.49%-66K101.96%2K--0---68K-------628K---102K
Other non- operating income (expenses) 1,069.33%727K-101.39%-145K-12.30%107K-9.29%-1.66M-589.45%-1.63M94.37%-75K-111.45%-72K121.14%122K-193.62%-1.52M---237K
Income before tax 94.12%7.63M-62.92%2.24M-62.86%4.64M130.17%23.22M100.77%772K-64.87%3.93M3.09%6.04M99.03%12.48M-917.73%-76.97M-100.28M
Income tax 57.64%1.69M-55.78%662K-64.61%901K-37.52%5.32M-70.96%203K-70.80%1.07M-28.17%1.5M23.95%2.55M67.03%8.52M699K
Net income 107.84%5.94M-65.27%1.58M-62.42%3.73M120.94%17.9M100.56%569K-61.97%2.86M20.37%4.54M135.59%9.94M-2,081.46%-85.48M-100.98M
Net income continuous Operations 107.84%5.94M-65.27%1.58M-62.42%3.73M120.94%17.9M100.56%569K-61.97%2.86M20.37%4.54M135.59%9.94M-2,081.46%-85.48M---100.98M
Minority interest income 34.30%2.33M12.28%1.13M-56.89%1.04M-22.00%5.81M2,203.45%668K-50.99%1.73M-47.31%1.01M21.79%2.4M270.43%7.45M29K
Net income attributable to the parent company 221.17%3.61M-87.47%442K-64.18%2.7M113.00%12.09M99.90%-99K-71.73%1.12M90.39%3.53M235.65%7.53M-4,137.05%-92.93M-101.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 221.17%3.61M-87.47%442K-64.18%2.7M113.00%12.09M99.90%-99K-71.73%1.12M90.39%3.53M235.65%7.53M-4,137.05%-92.93M-101.01M
Basic earnings per share 300.00%0.040-66.67%0.03109.93%0.140-80.74%0.0165.32%0.04207.16%0.09-4,790.77%-1.41-1.3187
Diluted earnings per share 200.00%0.0300103.55%0.050-80.74%0.01-58.67%0.012.39%0.03-4,790.77%-1.41-1.3187
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -